Company Announcements

Total Voting Rights - 31 May 2024

Source: RNS
RNS Number : 5492Q
Animalcare Group PLC
31 May 2024
 

Animalcare Group Plc

(the "Company" or the "Group")

Total Voting Rights - 31 May 2024

31 May 2024. For the purposes of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules ("DTRs"), the Company's issued share capital as at 31 May 2024 consisted of 60,374,268 ordinary shares of 20 pence each in the Company ("Ordinary Shares"). No shares are held in Treasury. Therefore, the total number of voting rights in the Company was 60,374,268.

 

The above figure of 60,374,268 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the DTRs.

For further information, please contact:

Animalcare Group Plc

Chris Brewster, Chief Financial Officer and
Company Secretary

+44 (0)1904 487 687

communications@animalcaregroup.com

Stifel Nicolaus Europe Limited

(Nominated Advisor & Joint Broker)

Ben Maddison

Nicholas Harland

Francis North

Tel: +44 (0)20 7710 7600

 

 

 

 

 

Panmure Gordon

(Joint Broker)

Corporate Finance

Freddy Crossley/Emma Earl

Corporate Banking

Rupert Dearden

+44 (0)20 7886 2500

 

About Animalcare

Animalcare Group plc is a UK AIM-listed international development-focused veterinary sales and marketing organisation. Animalcare operates in seven countries and exports to approximately 40 countries in Europe and worldwide. The Group is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.

For more information, please visit www.animalcaregroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRSDIFASELSESI